Condition: Venous Thromboembolism · Cancer · Upper Extremity Deep Vein Thrombosis · Sponsor: Ottawa Hospital Research Institute
This trial seeks to evaluate a management strategy after the acute treatment duration (≥ 3 months of therapeutic anticoagulation) for patients with cancer and catheter-related upper extremity deep vein thrombosis (DVT).
This description comes directly from the study's public registry record.
Tzu-Fei Wang, MD, MPH · 6137379988 · tzwang@toh.ca
Always discuss trial participation with your own doctor first.
| The Ottawa Hospital | Ottawa, Ontario, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06603870